Method of detecting and /or quantifying a specific ige antibody in a liguid sample
AssigneeALK-Abello A/S
InventorJOOST VAN NEERVEN
Life of this patent
Estimating the term…
Loading patent…
AssigneeALK-Abello A/S
InventorJOOST VAN NEERVEN
Estimating the term…
A method of detecting and/or quantifying an IgE antibody specific to a ligand in the form of antigen, antibody or hapten in a liquid sample comprising the steps of (a) contacting (i) the sample with (ii) a ligand in the form of an antigen, an antibody or a hapten to form a mixture I comprising IgE-containing complexes, (b) mixing mixture I with a carrier to which is bound (iii) IgE receptor, said IgE receptor being CD23 (FcεRII) and/or FcεRI, to form a mixture II comprising carrier-bound IgE-containing complexes, (c) separating the carrier-bound IgE-containing complexes from mixture II, and (d) determining the amount of the carrier-bound IgE-containing complexes formed.
A method of detecting and/or quantifying an IgE antibody specific to a ligand in the form of antigen, antibody or hapten in a liquid sample comprising the steps of
A method according to any of the preceding claims, wherein the ligand is bound to biotin or a functional derivative thereof.
A method according to any of the preceding claims, wherein the IgE-containing sample is contacted with the ligand and allowed to incubate to form a mixture I (step (a)) before contacting mixture I with the carrier/IgE receptor (step (b)).
A method according to any of the preceding claims, wherein the carrier is a particulate material.
A method according to any of the preceding claims, wherein the IgE to be detected is quantified using both CD23 alone to obtain a first measurement and using FcεRI alone to obtain a second measurement.
A method according to any of the preceding claims, wherein the number of ligand molecules is between 100% and 200% of the number of IgE molecules to be detected.
A method of detecting and/or quantifying a specific IgE antibody in a liquid sample comprising the steps of (a) contacting (i) the sample with (ii) a free ligand in the form of an antigen, an antibody or a hapten to form a mixture I comprising IgE-containing complexes, wherein the ligand is bound to biotin or a functional derivative thereof,
Dependencies are inferred from the claim text.